The Nasal drug delivery market is experiencing high growth and scientific developments, providing a non-invasive route for systemic and CNS therapies. Innovations in device design, formulation science, and targeting strategies are improving bioavailability, patient usability, and therapeutic precision. Direct to CNS delivery and the development pathway bring together patients, formulation, and device to treat unmet market needs. This session explores the latest scientific breakthroughs, device-formulation integration, and translational strategies that are shaping the future of nasal drug delivery and expanding its potential across therapeutic areas.
